SEC Info - Adamas Pharmaceuticals Inc. - ‘15-12B’ on 12/6/21

SEC Info℠

Home

Help

Please Sign In

Adamas Pharmaceuticals Inc. – ‘15-12B’ on 12/6/21

On: Monday, 12/6/21, at 5:25pm ET · Effective: 12/6/21 · Accession #: 1104659-21-146860 · File #: 1-36399

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/06/21  Adamas Pharmaceuticals Inc.       15-12B     12/06/21    1:12K                                    Toppan Merrill/FA

Certification of a Termination of Registration of a Class of Securities — Form 15 — § 12(b) – SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 15-12B      Certification of a Termination of Registration of   HTML      9K 
                a Class of Securities

This is an HTML Document rendered as filed. [ Alternative Formats ]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 001-36399

ADAMAS PHARMACEUTICALS, INC.

(Exact name of registrant as specified in its charter)

1900 Powell Street, Suite 1000

Emeryville, California

(510) 450-3500

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, par value $0.001 per share

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)		x
Rule 12g-4(a)(2)		¨
Rule 12h-3(b)(1)(i)		x
Rule 12h-3(b)(1)(ii)		¨
Rule 15d-6		¨
Rule 15d-22(b)		¨

Approximate number of holders of record as of the certification or notice date: One (1)

Pursuant to the requirements of the Securities Exchange Act of 1934, Adamas Pharamceuticals, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

	ADAMAS PHARMACEUTICALS, INC.

Date: December 6, 2021	By:	/s/ *Jack A. Khattar*
		Name: Jack A. Khattar
		Title: President, Treasurer and Secretary

Dates Referenced Herein

This ‘15-12B’ Filing	Date	Other Filings

Filed on / Effective on:	12/6/21	None on these Dates
		List all Filings

↑Top

Filing Submission 0001104659-21-146860 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Adamas Pharmaceuticals Inc. – ‘15-12B’ on 12/6/21

On: Monday, 12/6/21, at 5:25pm ET · Effective: 12/6/21 · Accession #: 1104659-21-146860 · File #: 1-36399

Certification of a Termination of Registration of a Class of Securities — Form 15 — § 12(b) – SEA’34Filing Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein

Certification of a Termination of Registration of a Class of Securities — Form 15 — § 12(b) – SEA’34

Filing Table of Contents